Key Record Dates
ClinicalTrials.gov Identifier: | NCT04511871 |
---|---|
Brief Title: | A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors |
First Submitted : | August 10, 2020 |
First Submitted that Met QC Criteria : | August 12, 2020 |
First Posted : | August 13, 2020 |
Last Update Submitted that Met QC Criteria : | April 14, 2023 |
Last Update Posted : | April 18, 2023 |